Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,14 USD | +0,97% | -3,94% | -24,73% |
Omzet 2022 | 9,01 mln. 8,46 mln. | Omzet 2023 | 3,31 mln. 3,11 mln. | Marktkapitalisatie | 48,89 mln. 45,89 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -29 mln. -27,22 mln. | Nettowinst (verlies) 2023 | -8 mln. -7,51 mln. | EV/omzet 2022 | 2,06 x |
Nettoliquiditeiten 2022 | 4,17 mln. 3,91 mln. | Nettoliquiditeiten 2023 | 15,11 mln. 14,19 mln. | EV/omzet 2023 | 10,2 x |
K/w-verhouding 2022 |
-0,74
x | K/w-verhouding 2023 |
-5,88
x | Werknemers | 8 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 87,83% |
Recentste transcriptie over Marker Therapeutics, Inc.
1 dag | +0,97% | ||
1 week | -3,94% | ||
Lopende maand | -3,72% | ||
1 maand | -5,91% | ||
3 maanden | -4,17% | ||
6 maanden | +27,78% | ||
Lopend jaar | -24,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Juan F. Vera
CEO | Chief Executive Officer | 44 | 17-10-18 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-11-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 63 | 17-10-18 | |
Steven Elms
BRD | Director/Board Member | 60 | 06-08-19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 08-12-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 4,1 | -4,87% | 13 170 |
17-04-24 | 4,31 | -2,05% | 10 686 |
16-04-24 | 4,4 | -0,90% | 15 037 |
15-04-24 | 4,44 | +3,02% | 31 885 |
12-04-24 | 4,31 | -6,30% | 20 306 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-24,73% | 36,5 mln. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |